K2 Principal Fund’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Hold
100,000
0.15% 117
2025
Q1
$1.13M Buy
+100,000
New +$1.13M 0.14% 113